NGVT (Ingevity) Cyclically Adjusted Revenue per Share: $37.52 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGVT Ingevity Corp NGVT
62 GF Score
Price $69.66
GF Value $46.12
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Ingevity Cyclically Adjusted Revenue per Share?

Ingevity NGVT -2.11% 62 Cyclically Adjusted Revenue per Share is $37.52 as of Jun. 2026. GuruFocus rates NGVT with a GF Score™ of 62/100 and a GF Value™ of $46.12 (Significantly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Ingevity's adjusted revenue per share for the three months ended in Jun. 2026 was $8.898. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $37.52 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Ingevity's average Cyclically Adjusted Revenue Growth Rate was 4.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-20), Ingevity's current stock price is $69.655. Ingevity's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was $37.52. Ingevity's Cyclically Adjusted PS Ratio of today is 1.86.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ingevity was 2.11. The lowest was 0.88. And the median was 1.36.


Ingevity  (NYSE:NGVT) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Ingevity's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=69.655/37.52
=1.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ingevity was 2.11. The lowest was 0.88. And the median was 1.36.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Ingevity Cyclically Adjusted Revenue per Share Related Terms


Ingevity Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Ingevity's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ingevity Cyclically Adjusted Revenue per Share Chart

Ingevity Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 35.22 36.27

Ingevity Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.97 36.29 36.27 37.02 37.52

NGVT vs CC, KWR, MTX: Cyclically Adjusted Revenue per Share Comparison

For the Specialty Chemicals subindustry, Ingevity's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ingevity Cyclically Adjusted PS Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Ingevity's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ingevity's Cyclically Adjusted PS Ratio falls into.


NGVT
62GF Score
Ingevity Corp NGVT
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ingevity Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ingevity's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=8.898/333.9520*333.9520
=8.898

Current CPI (Jun. 2026) = 333.9520.

Ingevity Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 5.995 241.428 8.293
201612 4.960 241.432 6.861
201703 5.156 243.801 7.063
201706 6.135 244.955 8.364
201709 6.207 246.819 8.398
201712 5.393 246.524 7.306
201803 5.521 249.554 7.388
201806 7.242 251.989 9.598
201809 7.295 252.439 9.651
201812 6.550 251.233 8.707
201903 6.553 254.202 8.609
201906 8.360 256.143 10.900
201909 8.440 256.759 10.977
201912 7.190 256.974 9.344
202003 6.868 258.115 8.886
202006 6.541 257.797 8.473
202009 8.002 260.280 10.267
202012 7.855 260.474 10.071
202103 7.870 264.877 9.922
202106 8.889 271.696 10.926
202109 9.530 274.310 11.602
202112 8.502 278.802 10.184
202203 9.749 287.504 11.324
202206 10.837 296.311 12.214
202209 12.640 296.808 14.222
202212 10.169 296.797 11.442
202303 10.457 301.836 11.570
202306 13.165 305.109 14.410
202309 12.257 307.789 13.299
202312 -2.883 306.746 -3.139
202403 9.378 312.332 10.027
202406 10.750 314.175 11.427
202409 9.147 315.301 9.688
202412 7.244 315.605 7.665
202503 6.762 319.799 7.061
202506 9.092 322.561 9.413
202509 9.014 324.800 9.268
202512 7.138 324.054 7.356
202603 7.167 330.213 7.248
202606 8.898 333.952 8.898

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $37.52 mean?
Ingevity (NGVT) has a Cyclically Adjusted Revenue per Share of $37.52 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ingevity and its competitors.
Is Ingevity's Cyclically Adjusted Revenue per Share too high?
Ingevity's current Cyclically Adjusted Revenue per Share is $37.52. Overall, Ingevity has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ingevity's Cyclically Adjusted Revenue per Share compare to CC and KWR?
Ingevity's Cyclically Adjusted Revenue per Share of $37.52 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Chemicals company?
A good Cyclically Adjusted Revenue per Share depends on the Chemicals industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ingevity and its competitors. Ingevity's current Cyclically Adjusted Revenue per Share is $37.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ingevity stock overvalued right now?
Based on GuruFocus' analysis, Ingevity (NGVT) is currently considered Significantly Overvalued. The stock's GF Value™ is $46.12, compared to a current price of $69.66 — trading 51% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $37.52. Ingevity's overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Ingevity (NGVT), the current Cyclically Adjusted Revenue per Share is $37.52 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ingevity (NGVT) Overvalued in 2026?

Based on GuruFocus' analysis, Ingevity stock appears to be overvalued. The current stock price of $69.66 is trading 51% above its estimated GF Value™ of $46.12. GuruFocus considers Ingevity to be Significantly Overvalued.

Key valuation signals for NGVT:

  • Cyclically Adjusted Revenue per Share: $37.52
  • GF Value™: $46.12 vs. price of $69.66 (51% above fair value)
  • GF Score™: 62/100 with 7 warning signs

No single metric tells the full story. See the NGVT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ingevity Business Description

Other Exchanges IGX:Germany
Address 4920 O\'Hear Avenue, Suite 400, North Charleston, SC, USA, 29405
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.
62GF Score

Get the complete analysis for NGVT

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$69.66
Price
$46.12
GF Value